Category: Africa

Posted on

Virsec Appoints Greg Kelton as Senior Regional Director for EMEA to Drive Next Stage of Growth Across the Region

Kelton will bring his 20+ years of software and sales experience to Virsec’s EMEA expansion mission

Greg Kelton

Senior Regional Director for EMEA

SAN JOSE, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) — Virsec, the only company to full protect software at the workload while it is running via their Deterministic Protection Platform (DPP), today announced the appointment of Greg Kelton as the new Senior Regional Director for EMEA, an appointment which will help to drive growth and expansion for Virsec in a key region.

Greg is a hugely experienced software executive, with 11 successful exits and 20+ years of sales and general manager experience at over a dozen software companies building and managing high performance teams across the United States and Europe, resulting in initial public offering or acquisition. He also brings his invaluable expertise in launching and achieving strong revenue growth in the EMEA division of software companies, with technology sector experience across application security, legal compliance, CRM, analytics, application performance monitoring, and open source, to name but a few.

Greg’s most recent positions were with Checkmarx, where he drove the expansion of secure coding in strategic accounts, and previously as managing director of EMEA for the open-source security division of Flexera, where he managed sales and customer success and led the go-to market effort, driving awareness of the company and vision as a keynote speaker at industry events.

“We’re delighted to have Greg on board, bringing his wealth of industry and sales experience to Virsec at this crucial juncture,” said Dave Furneaux, CEO of Virsec. “Greg’s understanding of the market, and of the region, places us in a winning position to deliver our dynamic solutions and ‘first principles’ approach to the EMEA market.”

“I’m delighted to be joining the Virsec team and helping to deliver their EMEA goals,” said Kelton. “Coming into Virsec at such a dynamic time when their innovative DPP solution has recently launched gives me an opportunity to work with a software protection tool that truly will be a game changer. I’m excited to have the opportunity to build the strength and presence of deterministic protection in EMEA.”

This announcement comes at the beginning of a landmark year for Virsec, one in which they have already announced their ‘End to Attacks on Server Infrastructure’ Deterministic Protection Platform (DPP), as well as the announcement of a new Chief Revenue Officer.

About Virsec
Virsec is on a mission to make security response obsolete. Taking a ‘first principles’ approach to protection, Deterministic Protection Platform (DPP) by Virsec automatically and consistently maps exactly what your software is supposed to do and stops, in milliseconds, any deviations — preventing attackers from leveraging vulnerabilities to execute control and run malicious code. DPP by Virsec is a proven technology that enables leading government and commercial organizations around the world to protect their server workloads, at runtime, against ransomware and other known and unknown threats, reduce operating costs and meet key compliance requirements. Virsec is headquartered in San Jose, California, with offices all over the world. For more information, please visit https://www.virsec.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d6d7e1d0-b431-42ce-8e3a-ec59deb18895

Media Contact:
Conor Heslin
Account Manager, Eskenzi PR for Virsec
conor@eskenzipr.com
0779541614

Posted on

Shincheonji Church Membership Grows in Europe, Despite Covid-19 and Religious Skepticism

NEW YORK, Feb. 21, 2022 /PRNewswire/ — Shincheonji Church of Jesus hosted an online press conference on February 18th with media representatives from 48 European countries. The event featured remarks by Shincheonji Chairman Man Hee Lee and followed press conferences previously held in the Philippines, the United States and Africa.

Chairman Man Hee Lee speaking at the Europe Press Conference on February 18, 2022

In response to questions regarding the declining number of Christians in Europe, Chairman Lee pointed out that today’s churches do not provide enough of an explanation about the words of the Bible that closely relate to the daily lives of individuals and communities. He also said that the detailed prophecies of the Bible were written as signs that occur in the future, and that testifying the fulfillment of the prophecies led to an increase in Shincheonji Church membership in Europe.

Chairman Lee also explained that according to the Bible, the number “666” mentioned in chapter 13 of Revelation is not about Covid-19 but a parable about King Solomon, representing a person who betrays God at the time of Revelation. He further said that “the whole book of Revelation is written in parables,” which can be understood “when what is prophesied (in parables) is fulfilled in the physical reality.”

A church leader attending the press conference asked how Chairman Lee came to understand the specific year, month, day and time in Revelation 9 as the words of prophecy. Chairman Lee replied, “Because I saw it at the site where the event happened. I tell what I came to see and hear.”

Samuel Kabo, pastor of the Evangelical Reformed Church of Alès in France, was also amazed by Chairman Lee’s ability to provide specific details regarding the fulfillment of Revelation. “I was very impressed that Chairman Lee testified without even looking at the book of Revelation,” Pastor Kabo said.” And concerning certain events such as the sixth trumpet, again there was a date. How did he know this date with so much precision, with the time?”

An official from Shincheonji Church of Jesus in Europe said, “The Covid-19 pandemic has brought disease, disaster, and hardship all over the world, while also limiting religious activities. Chairman Lee highlights that it is most important to interact with each other beyond religions. We hope that this event will serve as an opportunity to restore Christianity in Europe.”

For more information, please contact us at revelation@scjamericas.org.

Photo – https://mma.prnewswire.com/media/1750752/europe_pc.jpg

Posted on

Taconic Biosciences® Launches Cage+™, Redefining Colony Management Solutions for the Modern Laboratory

Stewardship Approach Safeguards All Elements of Contract Breeding Services

RENSSELAER, N.Y., Feb. 21, 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, launched Cage+, a holistic, innovative approach to murine contract breeding services. Cage+ delivers complete stewardship of projects from start to finish, allowing investigators to focus on research with confidence that animal model supply is reliable, at the highest quality, and on budget.

Biomedical and pharmaceutical research has profoundly changed over the past two decades. Studies are more advanced and rapid-paced, compressing the time to produce experimental data required to support well-informed decisions. The novel animal models generated to support these advanced studies have become more complex and precise. Yet, while the contract research service industry has kept pace with biomedical research advancements, the contract breeding industry has remained largely unchanged since the early 1990s. Most providers continue to place the project planning and management burden on investigators, who have neither the time nor expertise to direct service providers on how best to design and manage scaled production of complex animal models.

Taconic’s Cage+ Colony Management Solutions closes the gap between biomedical research program demands and the antiquated approach offered by many contract breeding services. Cage+ employs a holistic approach, combining standard animal breeding and husbandry elements with comprehensive breeding design expertise, project-specific methodology to reduce animal welfare concerns, budget monitoring, and proactive project management and communication. Additionally, this all-encompassing program rapidly expands breeding production through expert-led embryology methods, delivers internationally harmonized animal health standards, and includes the eTACONIC® web-based project management tool, providing users access to colony information 24/7.

Cage+ allows investigators to fully leverage proven expertise in complex model design and breeding to advance research programs. When coupled with Taconic’s Custom Model Generation Solutions, Cage+ Colony Management Solutions brings a comprehensive and seamless “design to management” service, allowing clients to leverage the most complex genetically engineered models from initial design through to scaled production of study cohorts.

“Researchers should demand better from contract breeding service providers, and this view is the driving factor behind our Cage+ stewardship-based approach to colony management solutions,” said Dr. John Couse, vice president, scientific services. “With Cage+, researchers will view Taconic as an extension of their team, leveraging the collaboration of scientists and experts. Our approach allows investigators to focus their time, energy, and resources on research while trusting their custom model animal development and production to Taconic.”

To learn more about how Cage+ can improve your colony management experience and outcomes, please call 1-888-TACONIC (1-888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com.

About Taconic Biosciences, Inc. 
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates laboratories and breeding facilities in the US and Europe, maintains distributor relationships in Asia, and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact: 
Aidan Bouchelle
Associate Director, Marketing Operations
1-518-949-7598
Aidan.Bouchelle@taconic.com

Posted on

Taconic Biosciences® lance Cage+™, redéfinissant les solutions de gestion de colonies pour le laboratoire moderne

L’approche de gestion protège tous les éléments des services d’élevage sous contrat

RENSSELAER, New York, 21 févr. 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, un leader mondial dans la fourniture de solutions de modèles animaux pour la découverte de médicaments, a lancé Cage+, une approche holistique et innovante des services d’élevage de modèles murins sous contrat. Cage+ fournit une gestion complète des projets du début à la fin, permettant aux chercheurs de se concentrer sur la recherche avec l’assurance que l’approvisionnement en modèles animaux est fiable, de la plus haute qualité et conforme à leur budget.

La recherche biomédicale et pharmaceutique a profondément changé au cours des vingt dernières années. Les études sont plus avancées et plus rapides, ce qui réduit le temps nécessaire à la production de données expérimentales requises pour prendre des décisions bien éclairées. Les nouveaux modèles animaux générés pour soutenir ces études avancées sont devenus plus complexes et plus précis. Pourtant, alors que le secteur des services de recherche sous contrat a suivi le rythme des progrès de la recherche biomédicale, le secteur de l’élevage sous contrat est resté dans une large mesure inchangé depuis le début des années 1990. La plupart des fournisseurs continuent de faire peser la charge de la planification et de la gestion des projets sur les chercheurs, qui n’ont ni le temps ni l’expertise nécessaires pour orienter les prestataires de services sur la meilleure façon de concevoir et de gérer la production à grande échelle de modèles animaux complexes.

La solution de gestion de colonies Cage+ de Taconic comble le fossé entre les demandes de programmes de recherche biomédicale et l’approche obsolète offerte par de nombreux services d’élevage sous contrat. Cage+ emploie une approche holistique, combinant des éléments de production animale et d’élevage standard avec une expertise complète en conception d’élevage, une méthodologie spécifique à chaque projet pour réduire les préoccupations relatives au bien-être animal, un suivi budgétaire, ainsi qu’une gestion et une communication proactives du projet. En outre, ce programme global élargit rapidement la production d’élevage grâce à des méthodes embryologiques menées par des experts, fournit des normes de santé animale harmonisées à l’échelle internationale et inclut l’outil de gestion de projets basé sur le web eTACONIC®, fournissant aux utilisateurs un accès aux informations sur les colonies 24h/24, 7j/7.

Cage+ permet aux chercheurs de tirer pleinement parti de cette expertise éprouvée dans la conception et l’élevage de modèles complexes pour faire progresser les programmes de recherche. Associée aux solutions de génération de modèles personnalisés de Taconic, la solutions de gestion de colonies Cage+ apporte un service de « conception à gestion » complet et transparent, permettant aux clients de tirer parti des modèles génétiquement modifiés les plus complexes, depuis la conception initiale jusqu’à la production à grande échelle de cohortes d’étude.

« Les chercheurs devraient exiger davantage des fournisseurs de services d’élevage sous contrat, et cette perspective est le facteur qui a motivé la création de notre approche basée sur la gestion Cage+ en matière de solutions de gestion de colonies », a déclaré le Dr John Couse, vice-président des services scientifiques. « Avec Cage+, les chercheurs considéreront Taconic comme une extension de leur équipe, en tirant parti de la collaboration de scientifiques et d’experts. Notre approche permet aux chercheurs de concentrer leur temps, leur énergie et leurs ressources sur la recherche tout en faisant confiance à Taconic pour le développement et la production de leurs modèles animaux personnalisés. »

Pour en savoir plus sur la manière dont Cage+ peut améliorer votre expérience de gestion de colonies et vos résultats, veuillez composer le 1-888-TACONIC (1-888-822-6642) aux États-Unis, le +45 70 23 04 05 in Europe, ou envoyer un e-mail à l’adresse info@taconic.com.

À propos de Taconic Biosciences, Inc. 
Taconic Biosciences est un chef de file mondial entièrement autorisé dans les modèles et les services de rongeurs génétiquement modifiés. Fondée en 1952, Taconic offre les meilleures solutions animales afin que les clients puissent acquérir, générer d’une manière personnalisée, élever, pré-conditionner, tester et distribuer des modèles de recherche précieux dans le monde entier. Spécialiste des modèles de souris et de rats génétiquement modifiés, du microbiome, des modèles de souris pour l’immuno-oncologie et des services de conception de modèles intégrés et d’élevage, Taconic exploite des laboratoires et des établissements d’élevage aux États-Unis et en Europe, entretient des relations de distribution en Asie et dispose de capacités d’expédition mondiales pour fournir des modèles animaux presque partout dans le monde.

Contact auprès des médias : 
Aidan Bouchelle
Directeur associé des opérations marketing
1-518-949-7598
Aidan.Bouchelle@taconic.com

Posted on

Taconic Biosciences® Lança Cage+™, Redefinindo Soluções de Gestão de Colônias para o Laboratório Moderno

A Abordagem de Manejo Protege Todos os Elementos dos Serviços de Criação por Contrato

RENSSELAER, NY, Feb. 21, 2022 (GLOBE NEWSWIRE) — A Taconic Biosciences, líder global no fornecimento de soluções de modelo de animais para a descoberta de medicamentos, lançou Cage+, uma abordagem inovadora aos serviços de criação de murinos por contrato. O Cage+ oferece uma gestão completa dos projetos, permitindo que os pesquisadores se concentrem na pesquisa com confiança de que o fornecimento de modelos animais é confiável, da mais alta qualidade e que está dentro do orçamento.

A pesquisa biomédica e farmacêutica mudou profundamente nas últimas duas décadas. Os estudos são mais rápidos e avançados, reduzindo o tempo para a produção dos dados experimentais necessários para o apoio das decisões bem-informadas. Os novos modelos animais gerados para apoiar esses estudos avançados tornaram-se mais complexos e precisos. No entanto, embora a indústria de serviços de pesquisa por contrato tenha acompanhado os avanços da pesquisa biomédica, a indústria de criação por contrato permaneceu em grande parte inalterada desde o início da década de 1990. A maioria dos provedores continua a colocar a responsabilidade do planejamento e do gerenciamento do projeto nos pesquisadores que não têm tempo nem experiência para direcionar os provedores de serviços sobre a melhor forma de projetar e gerenciar a produção em escala de modelos animais complexos.

As Soluções de Gestão de Colônias Cage+ fecha a lacuna entre as demandas do programa de pesquisa biomédica e a abordagem antiquada oferecida por muitos serviços de criação por contrato. O Cage+ emprega uma abordagem holística, combinando elementos padrão de criação e pecuária com conhecimentos abrangentes de design de criação, metodologia específica do projeto para reduzir as preocupações com o bem-estar animal, monitoramento orçamentário e gerenciamento e comunicação proativos do projeto. Além disso, este programa abrangente expande rapidamente a produção da criação através de métodos de embriologia liderados por especialistas, fornece padrões de saúde animal harmonizados internacionalmente e inclui a ferramenta de gerenciamento de projetos eTACONIC® com base na web, fornecendo aos usuários acesso a informações sobre colônias 24 horas por dia, 7 dias por semana.

A Cage+ permite que os pesquisadores aproveitem totalmente a experiência comprovada em design e criação de modelos complexos para avançar nos programas de pesquisa. Quando combinada com as Soluções de Geração de Modelos Personalizados da Taconic, a Cage+ Colony Management Solutions oferece um serviço de “design para gerenciamento” abrangente e contínuo, permitindo que os clientes aproveitem os modelos geneticamente modificados mais complexos, desde o design inicial até a produção em escala de coortes de estudo.

“Os pesquisadores devem exigir mais dos provedores de serviços de criação por contrato, e essa visão é o condutor da nossa abordagem com base na gestão do Cage+ de soluções de gestão de colônias”, disse o Dr. John Couse, vice-presidente de serviços científicos. “Com o Cage+, os pesquisadores verão a Taconic como uma extensão da sua equipe, para a colaboração de cientistas e especialistas. Nossa abordagem permite que os pesquisadores concentrem seu tempo, energia e recursos na pesquisa, confiando seu modelo personalizado de desenvolvimento e produção animal à Taconic.”

Para mais informações sobre como melhorar a gestão das colônias e dos resultados da CAge+, ligue para 1-888-TACONIC (1- 888- 822- 6642) nos EUA, +45 70 23 04 05 na Europa, ou envie email para info@taconic.com.

Sobre a Taconic Biosciences, Inc.
A Taconic Biosciences é uma líder global totalmente licenciada em serviços e modelos geneticamente modificados. Fundada em 1952, a Taconic oferece as melhores soluções/modelos de pesquisas em murinos, para que os clientes possam adquirir, customizar, criar, pré-condicionar, testar e distribuir valiosos modelos de pesquisa em todo o mundo. Especializada em modelos de camundongos e de ratos geneticamente projetados, microbioma, modelos de camundongos imuno-oncologia, e serviços de design e criação de modelos integrados, a Taconic opera laboratórios de serviços e instalações de criação nos EUA e na Europa, mantém relações com distribuidores na Ásia , e tem capacidades de entrega em nível global para oferecer modelos em quase qualquer lugar no mundo.

Contato com a Mídia: 
Aidan Bouchelle
Diretor Associado, Operações de Marketing
1-518-949-7598
Aidan.Bouchelle@taconic.com

Proudly powered by WordPress